Try our business solution for free!

Aurobindo Pharma's EBITDA margin FY 2013-2022

Published by
Sanyukta Kanwal,
Sep 12, 2022
In fiscal year 2022, Aurobindo Pharma's EBITDA margin was around 19 percent, indicating an decrease compared to the previous fiscal year. The Indian company's EBITDA was valued at around 44 billion Indian rupees in fiscal year 2022.

Share of EBITDA margin of Aurobindo Pharma Limited in India from financial year 2013 to 2022

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2022

Region

India

Survey time period

FY 2013 to FY 2022

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2020 started in April 2019 and ended in March 2020.

One Indian rupee is equal to 0.012 euros and 0.013 U.S. dollars as of September 2022.

Values have been rounded for clarity.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics

Statistics on GlaxoSmithKline Pharmaceuticals Limited India

Overview

8

Key figures

6

Major players

5

Further related statistics

16

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.PfizerNovartis
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu